Topics

NIHR, MRC buddy up to tackle global chronic disease

07:44 EDT 28 Oct 2019 | PharmaTimes

The organisations announced plans to invest over £6 million in five implementation science projects focused on tackling diabetes and hypertension in low- and middle-income countries.

Original Article: NIHR, MRC buddy up to tackle global chronic disease

NEXT ARTICLE

More From BioPortfolio on "NIHR, MRC buddy up to tackle global chronic disease"

Quick Search

Relevant Topic

Adempas (riociguat)
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...